Paragas, Aennoh Kish J.

HRN: 20-85-08  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/14/2022
CEFUROXIME 750MG (VIAL)
06/14/2022
06/20/2022
IV
265mg
Q8
T/c UTI, WBC 21
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: